Medicago announces production of viable vaccine candidate for COVID-19

Medicago, a biopharmaceutical company headquartered in Quebec City, Canada has announced that they have successfully pro...

March 27, 2020 | Friday | News
Novavax, Serum Institute of India to co-develop malaria Vaccine

Novavax and Serum Institute of India (SII) has announced a commercial license agreement for the use of Novavax’ pr...

March 17, 2020 | Tuesday | News
CEPI expands investment in COVID-19 vaccine development

CEPI, the Coalition for Epidemic Preparedness Innovations, on 10 March 2020 announced the expansion of its COVID-19 vacc...

March 11, 2020 | Wednesday | News
SII expects human trials for COVID-19 vaccine in 6 months

Serum Institute of India Pvt. Ltd. (SIIPL), the world's largest vaccine manufacturer by number of doses produced and sol...

February 20, 2020 | Thursday | News
NUS works on COVID-19 vaccine trial and rapid test kits

Scientists from the National University of Singapore (NUS) community are working on a vaccine trial and rapid detection ...

February 19, 2020 | Wednesday | News
WuXi Vaccines to build integrated manufacturing facility

WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologi...

February 18, 2020 | Tuesday | News
Pfizer Vaccines launches global centers of excellence network

Pfizer Inc. has announced the launch of its Vaccines Division’s Centers of Excellence Network, a global program of...

January 24, 2020 | Friday | News
Sinovac receives China's approval for varicella vaccine

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that the China National Medica...

December 31, 2019 | Tuesday | News
Merck gets FDA nod for Ebola vaccine

The U.S. Food and Drug Administration has announced the approval of Ervebo, the first FDA-approved vaccine for the preve...

December 23, 2019 | Monday | News
Vaccitech provides update for its Phase 2 Universal Influenza studies

Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infecti...

November 25, 2019 | Monday | News
NEC, VAXIMM to advance personalized neoantigen cancer vaccines

Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focu...

November 15, 2019 | Friday | News
Takeda’s Dengue vaccine candidate reveals protection in children

Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of ...

November 8, 2019 | Friday | News
FDA approves Sanofi’s Influenza Vaccine for older people

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone®&n...

November 5, 2019 | Tuesday | News
The Union reports efficacy of its TB Vaccine Candidate

International Union Against Tuberculosis and Lung Disease (The Union) headquartered in France, announces the Phase IIb T...

October 30, 2019 | Wednesday | News
NIH awards contracts to advance tuberculosis immunology research

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarde...

September 27, 2019 | Friday | News
Alwaleed Philanthropies invests $5 M in global fight for vaccines

Alwaleed Philanthropies, chaired by HRH Prince Alwaleed Bin Talal Bin Abdulaziz AlSaud, the global philanthropic fo...

September 2, 2019 | Monday | News
Crozet partners with PHV to develop Nipah virus vaccine

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (P...

August 28, 2019 | Wednesday | News
Zuellig Pharma, NICVB, NIHE team up for accessibility of vaccines

The National Institute of Vaccines and Medical Biologicals (NICVB), the National Institute of Hygiene and Epidemiology (...

April 23, 2019 | Tuesday | News